Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Current Assets of $6.1 million for Q1 2026, down 22.76% year-over-year from $7.8 million in Q1 2025, and down 18.11% quarter-over-quarter from $7.4 million in Q4 2025.
Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Current Assets for 17 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 22.76% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (down 22.76% YoY), while the FY2025 annual figure was $7.4 million, up 20.6% from the prior year.
- Current Assets declined to $6.1 million in Q1 2026 per CELZ's latest filing, from $7.4 million in the prior quarter.
- Across five years, Current Assets topped out at $22.9 million in Q2 2022 and bottomed at $5.4 million in Q3 2025.
- Historically, Current Assets has averaged $11.0 million across 5 years, with a median of $9.2 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets jumped 14370.99% — and 2024, when it slumped 47.43%.
- Creative Medical Technology Holdings' Current Assets stood at $18.7 million in 2022, then sank by 45.21% to $10.3 million in 2023, then slumped by 40.27% to $6.1 million in 2024, then rose by 20.6% to $7.4 million in 2025, then fell by 18.11% to $6.1 million in 2026.
- Business Quant data shows CELZ's Current Assets at $6.1 million in Q1 2026, $7.4 million in Q4 2025, and $5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.02 Mn |
| Mar 31, 2026 | 6.06 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 6.14 Mn |
| Sep 30, 2024 | 6.33 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Sep 30, 2023 | 12.04 Mn |
| Jun 30, 2023 | 13.73 Mn |
| Mar 31, 2023 | 14.81 Mn |
| Dec 31, 2022 | 18.75 Mn |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 22.95 Mn |
| Mar 31, 2022 | 9.23 Mn |
| Dec 31, 2021 | 10.74 Mn |
| Sep 30, 2021 | 2.58 Mn |